UK markets closed

Bioventus Inc. (BVS)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
3.9600-0.1100 (-2.70%)
At close: 04:00PM EDT
3.9600 0.00 (0.00%)
After hours: 04:00PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-127,138
-156,230
-158,704
19,375
16,411
Depreciation & amortisation
55,333
57,365
55,398
34,875
28,643
Deferred income taxes
-55,207
-2,377
-46,658
-9,756
644
Stock-based compensation
20,262
2,722
17,585
19,844
0
Change in working capital
-25,773
-3,181
-29,730
-15,145
15,308
Accounts receivable
-19,743
10,055
-17,672
-20,052
-3,941
Inventory
-6,934
-5,991
-18,618
3,183
-528
Other working capital
-28,625
7,982
-25,057
2,101
51,127
Other non-cash items
-19,669
2,426
1,490
-1,357
455
Net cash provided by operating activities
-5,664
15,344
-13,537
22,991
71,799
Cash flows from investing activities
Investments in property, plant and equipment
-22,961
-7,362
-11,520
-20,890
-20,672
Acquisitions, net
-320,921
0
0
-262,870
0
Other investing activities
-
-
-75
-
-
Net cash used for investing activities
-334,311
15,807
-116,436
-283,760
-20,500
Cash flows from financing activities
Debt repayment
-138,528
-87,264
-45,038
-111,250
-59,000
Common stock issued
5,625
778
5,822
109,410
0
Dividends paid
-184
-
0
-367
-19,886
Other financing activities
-5,203
-4,167
-3,367
-2,242
317
Net cash used provided by (used for) financing activities
243,822
-26,653
62,076
273,371
-29,569
Net change in cash
-96,535
5,127
-67,376
12,374
22,319
Cash at beginning of period
130,917
31,837
99,213
86,839
64,520
Cash at end of period
34,764
36,964
31,837
99,213
86,839
Free cash flow
Operating cash flow
-5,664
15,344
-13,537
22,991
71,799
Capital expenditure
-22,961
-7,362
-11,520
-20,890
-20,672
Free cash flow
-28,625
7,982
-25,057
2,101
51,127